Skip to main content

Table 9 In vitro cytotoxic screening of 6a–n against MDA-MB-231 human breast cancer cells

From: Bioactive fluorenes. Part III: 2,7-dichloro-9H-fluorene-based thiazolidinone and azetidinone analogues as anticancer and antimicrobial against multidrug resistant strains agents

Comp.

Validity (%) for sample Concentrations (µg/mL)

IC50 (µg/mL)

0

1

10

31.25

62.50

125

250

500

6a

100

99.4

92.4

90.7

83.1

78.3

69.6

63.2

612

6b

100

95.9

93.4

89.7

84.2

79.8

72.9

68.9

749

6c

100

92.8

77.8

63.1

53.1

46.04

29.4

24.8

104

6d

100

93.3

89.1

75.8

63.3

53.1

27.7

24.00

169

6e

100

98.2

90.2

89.9

85.2

69.2

41.9

39.4

215

6f

100

91.8

89.6

83.00

72.4

59.7

37.2

28.9

188

6g

100

96.7

93.9

91.2

82.9

71.1

65.5

55.6

576

6h

100

94.3

90.4

85.8

77.8

73.6

68.5

65.8

685

6i

100

94.2

89.1

66.8

55.9

49.2

24.3

18.2

120

6j

100

96.3

92.9

75.6

73.1

69.01

53.2

50.6

508

6k

100

96.4

90.7

78.6

69.6

51.00

33.3

19.1

131

6l

100

96.9

90.4

85.5

71.9

69.8

66.7

60.9

603

6m

100

93.2

89.9

77.6

73.2

67.1

63.4

59.5

590

6n

100

96.2

89.5

86.8

81.3

73.2

67.1

59.2

584